Poster

Establishment of a quality-driven manufacturing process to reprogram human donor material into human induced pluripotent stem cells to support drug discovery

Establishment of a quality-driven manufacturing process to reprogram human donor material into human induced pluripotent stem cells (iPSCs) to support drug discovery

Utilizing flow cytometry within a quality control process for an iPSC-based manufacturing facility

Characterizations of iPSC derived axoCells^TM cortical inhibitory interneurons

Functional and pharmacological differences between the contractility of axoCells^TM iPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 96

PC006 Functional and pharmacological differences between the contractility of axoCells iPSC-derived atrial and ventricular cardiomyocyt

Cross-platform validation of axoCells^TM hiPSC derived cardiomyocytes as a better human model for pre-clinical cardiotoxicity studies

Generation and characterization of cryopreserved axoCells^TM human iPSC-derived microglia

Poster: Generation and characterization of cryopreserved poster

Characterization of iPSC derived motor neurons using an accelerated maturation protocol

Functional maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture

Axol-Bioscience-human-iPSC-image-A-drug-discovery-platform-for-the-identification-of-novel-infarct-sparing-agents-for-treatment-of-ischemic-heart-diesase.jpg

Development of a scalable, high-throughput-compatible assay to detect tau aggregates using iPSC-derived cortical neurons maintained in a 3D-culture

Axol-Bioscience-human-iPSC-image-Modelling-Alzheimers-disease-Development-of-a-scalable-high-throughput-compatible-assay.jpg